The Week in Review: Dec 7 – Dec 14, 2018

Friday, Dec 14, 2018 News Recap: COMMUNITY DINNER January 10th at OUR PLACE in HONOUR of PHIL WILKIN Philip Wilkin, who passed away unexpectedly on Nov. 24th, 2018, was a man with the true spirit of giving. Phil sat on various committees designed to improve health and welfare of prisoners within the Canadian Prison System, and actively advocated for education, treatment and prevention. To help celebrate his achievements, HepCBC has set up a GoFundMe...

Hepatitis C highlights from The Liver Meeting 2018

This year at The Liver Meeting, data presented on hepatitis C treatment highlighted continued significantly positive outcomes from direct-acting antiviral therapy, reduced rates of hepatocellular carcinoma, and improved outreach and screening techniques. Healio Gastroenterology and Liver Disease has compiled the following reports which include presentations on nearly perfect sustained virologic response rates with Mavyret for 8 weeks, failure and retreatm

The Week in Review: Nov 2 – Nov 9, 2018

Friday, Nov 9, 2018 News Recap: Gilead Presents Latest Data from Viral Hepatitis Research Programs at The Liver Meeting® 2018 Gilead Sciences announced results from studies investigating Epclusa in chronic HCV patients with severe renal impairment undergoing dialysis and Harvoni in pediatric HCV patients aged three to five years. As well there was data from Gilead’s HBV cure development program. High Prevalence of Cirrhosis in Adults with Chronic...

Gilead Presents Latest Data from Viral Hepatitis Research Programs at The Liver Meeting® 2018

SAN FRANCISCO--(BUSINESS WIRE)--Nov 9, 2018--Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from studies investigating Epclusa ® (sofosbuvir 400mg/velpatasvir 100mg) in chronic hepatitis C virus (HCV) infected patients with severe renal impairment undergoing dialysis and Harvoni ® (ledipasvir/sofosbuvir) in pediatric HCV patients aged three to five years, adding to the efficacy and safety profile of sofosbuvir-based regimens across diverse pa